COVID-19 is associated with cardiovascular , neurological , and autoimmunity complications. In addition, the incidence of new-onset type 1 diabetes (T1D) increased during the pandemic; the CDC also reported that pediatric patients with COVID-19 were more likely to be diagnosed with diabetes after infection. However, whether COVID-19 is associated with new-onset T1D among pediatric patients remains unclear.

A retrospective cohort study evaluated whether COVID-19 increases the new-onset T1D among children. The study Data obtained from the TriNetX Analytics Platform Matched cohort: Patients with COVID-19 (2,85,628) and non-COVID-19 respiratory infections (2,85,628), aged ≀18 years Findings The diagnoses of new-onset T1D increased after one, three, and six months of COVID-19 infection compared to patients with other respiratory infections. 0-18 age group - 123 patients (0.043%) were…